Ticker | $ Bought |
---|---|
johnson & johnson | 6,110,000 |
regeneron pharmaceuticals | 2,100,000 |
Ticker | % Inc. |
---|---|
jazz pharmaceuticals plc | 63.67 |
vanda pharmaceuticals inc | 35.86 |
supernus pharmaceuticals inc | 9.35 |
united therapeutics corp | 2.97 |
indivior plc | 0.94 |
avadel pharmaceuticals | 0.93 |
Ticker | % Reduced |
---|---|
exelixis inc | -43.82 |
cardinal health inc | -29.14 |
biontech se-adr | -16.2 |
enanta pharmaceuticals inc | -0.1 |
gsk plc-spon adr | -0.1 |
sanofi-adr | -0.1 |
Ticker | $ Sold |
---|---|
mural oncology plc | -89,000 |
Krensavage Asset Management, LLC has about 74.4% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 74.4 |
Others | 25.6 |
Krensavage Asset Management, LLC has about 31.6% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
LARGE-CAP | 28.4 |
UNALLOCATED | 25.6 |
MID-CAP | 23.9 |
SMALL-CAP | 10.4 |
MICRO-CAP | 8.5 |
MEGA-CAP | 3.2 |
About 38.2% of the stocks held by Krensavage Asset Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
Others | 61.7 |
RUSSELL 2000 | 22 |
S&P 500 | 16.2 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Krensavage Asset Management, LLC has 15 stocks in it's portfolio. About 86.1% of the portfolio is in top 10 stocks. UTHR proved to be the most loss making stock for the portfolio. EXEL was the most profitable stock for Krensavage Asset Management, LLC last quarter.
Last Reported on: 15 Aug, 2025Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
UTHR | united therapeutics corp | 15.38 | 101,146 | 29,064,000 | added | 2.97 | ||
Historical Trend of UNITED THERAPEUTICS CORP Position Held By Krensavage Asset Management, LLCWhat % of Portfolio is UTHR?:Number of UTHR shares held:Change in No. of Shares Held: | ||||||||
CAH | cardinal health inc | 11.89 | 133,745 | 22,469,000 | reduced | -29.14 | ||
EXEL | exelixis inc | 11.51 | 493,526 | 21,752,000 | reduced | -43.82 | ||
JAZZ | jazz pharmaceuticals plc | 9.26 | 164,816 | 17,490,000 | added | 63.67 | ||
ENTA | enanta pharmaceuticals inc | 8.46 | 2,114,440 | 15,985,000 | reduced | -0.1 | ||
SUPN | supernus pharmaceuticals inc | 7.88 | 472,376 | 14,889,000 | added | 9.35 | ||
indivior plc | 7.60 | 974,474 | 14,364,000 | added | 0.94 | |||
gsk plc-spon adr | 5.52 | 271,729 | 10,434,000 | reduced | -0.1 | |||
avadel pharmaceuticals | 4.49 | 958,877 | 8,486,000 | added | 0.93 | |||
biontech se-adr | 4.14 | 73,382 | 7,813,000 | reduced | -16.2 | |||
sanofi-adr | 3.81 | 148,946 | 7,196,000 | reduced | -0.1 | |||
JNJ | johnson & johnson | 3.23 | 40,000 | 6,110,000 | new | |||
ALKS | alkermes plc | 3.15 | 207,822 | 5,946,000 | unchanged | 0.00 | ||
VNDA | vanda pharmaceuticals inc | 2.56 | 1,024,880 | 4,837,000 | added | 35.86 | ||
REGN | regeneron pharmaceuticals | 1.11 | 4,000 | 2,100,000 | new | |||
mural oncology plc | 0.00 | 0.00 | 0.00 | sold off | -100 | |||